home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Genetic News | search  
 

Henrietta's Legacy

 
  August, 22 2007 18:17
your information resource in human molecular genetics
 
     
Over fifty years ago, a 31-year-old woman underwent a biopsy for a suspicious cervical mass. Part of the sample went for pathological analysis, but another went to the research laboratory of George and Martha Gey. The patient died from her cancer just 8 months later, and on that day George Gey appeared on American TV announcing the dawn of a new era in medical research. For the first time, he explained, it was possible to grow human cells continuously in culture. And he called the biopsy-derived cell line 'HeLa', in memory of Henrietta Lacks, the unfortunate young mother whose tumour made it all possible.

Since then, researchers have been slowly stripping away the many secrets that endow cancer cells with the gift of immortality. In a review in Nature, Toren Finkel and colleagues not only offer a historical perspective, but also describe the more recent research linking cancer biology to normal ageing.

CONTACT

Toren Finkel (National Heart, Lung and Blood Institute, NIH, Bethesda, MD, USA)
E-mail: finkelt@nih.gov

NHLBI Communications Office, NIH, Bethesda, MD, USA
E-mail: nhlbi_news @nhlbi.nih.gov

(C) Nature press release.


Message posted by: Trevor M. D'Souza

print this article mail this article
Bookmark and Share this page (what is this?)

Social bookmarking allows users to save and categorise a personal collection of bookmarks and share them with others. This is different to using your own browser bookmarks which are available using the menus within your web browser.

Use the links below to share this article on the social bookmarking site of your choice.

Read more about social bookmarking at Wikipedia - Social Bookmarking

Latest News
Variants Associated with Pediatric Allergic Disorder

Mutations in PHF6 Found in T-Cell Leukemia

Genetic Risk Variant for Urinary Bladder Cancer

Antibody Has Therapeutic Effect on Mice with ALS

Regulating P53 Activity in Cancer Cells

Anti-RNA Therapy Counters Breast Cancer Spread

Mitochondrial DNA Diversity

The Power of RNA Sequencing

‘Pro-Ageing' Therapy for Cancer?

Niche Genetics Influence Leukaemia

Molecular Biology: Clinical Promise for RNA Interference

Chemoprevention Cocktail for Colon Cancer

more news ...

Generated by News Editor 2.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2017 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.